Anti-HIV agents with dual sites of action

Details Anti-HIV agents with dual sites of action Anti-HIV agents with dual sites of action

2008-06-03

2008-06-03

Badio, Barbara P. (Department: 1612)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

C552S510000

Reexamination Certificate

active

07381717

ABSTRACT:
The present invention provides compounds of the general structure:which are substituted at the 3 and 28 positions, along with pharmaceutical formulations containing the same and methods of treating viral infections employing the same.

REFERENCES:
patent: 5468888 (1995-11-01), Bouboutou et al.
patent: 5679828 (1997-10-01), Lee et al.
patent: 5962527 (1999-10-01), Pezzuto et al.
patent: 6048847 (2000-04-01), Ramadoss et al.
patent: 6172110 (2001-01-01), Lee et al.
patent: 6369101 (2002-04-01), Carlson
patent: 6369109 (2002-04-01), Debatin et al.
patent: 6403816 (2002-06-01), Jaggi et al.
patent: 6458834 (2002-10-01), Glinski et al.
patent: 6495600 (2002-12-01), Pezzuto et al.
Ma et al. “Chemical Modification of Oleanene Type Triterpenes and their Inhibitory Activity Against HIV-1 Protease Dimerization”Chem Pharm Bull48(11): 1681-1688 (2000).

Affiliated with

Also associated with

Rating

Anti-HIV agents with dual sites of action does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-HIV agents with dual sites of action, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-HIV agents with dual sites of action will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2808692